Marker staining |
Conventional markers, such as Iba-1, F4/80, Cd11b |
|
|
[2] |
Microglial specific markers, such as P2ry12, Tmem119 |
|
|
[3,92,95] |
Chimaeras |
Bone marrow chimera |
|
|
[2] |
Bone marrow chimera with lead head shielding |
|
|
[11] |
Circulating monocyte-labeling |
Systemic 5- ethynyl-2′- deoxyuridine (EdU) |
A traceable nucleotide that is integrated into the DNA of dividing cells
Efficient labeling short-lived circulating monocytes and MdCs but not long-lived microglia in steady state.
Nuclear stain, avoids confounding with (i) MNP auto-fluorescence and (ii) positivity due to transfer (phagocytosis) of reporter proteins
|
Require repeated injections, which limits use for short-term study but not chronic conditions.
Microglia may replicate during degeneration, local injections necessary for distinction
|
[6] |
Intravenously injected fluorescent tracers |
|
|
[72] |
Reporter mice |
Cx3cr1GFP or Cx3cr1YFP
|
|
|
[11,14,105] |
Ccr2RFP
|
|
Not good for labeling monocyte-derived macrophages, which lose Ccr2 expression
Spares non-classical monocytes
|
[6,7,34] |
Cx3cr1CreER
R26fl-STOP-fl-reporter
|
Tamoxifen treatment induces the expression of reporter and labels microglia and MdCs
The reporter expression in monocytes is ‘washed out’, as they are quickly replaced by non-labeled cells once tamoxifen decayed
|
|
[9,11,34,84,85] |
Depletion / recruitment inhibition studies |
Csf1r antagonists |
|
|
[97,98,127] |
Intravenous clodronate liposome |
|
Require repeated injections, which limits it for short-term study but not chronic conditions.
Potential off-target effects
|
[6,98] |
Cx3cr1CreER
R26fl-STOP-fl-DTA
|
|
|
[37,113] |
Cx3cr1CreER
R26fl-STOP-fl-DTR
|
|
|
[3,84] |
Ccl2- and Ccr2- deletion / inhibition |
|
|
[6–7, 73–80] |